Acquisition Alignment Leverage Arthrex's ownership of Celling Biosciences to pursue co development or distribution partnerships that embed point of care regenerative systems into Arthrex's surgical devices portfolio, expanding reach into orthopedic and sports medicine clinics.

In Clinic Growth Target clinics performing autologous therapies with an integrated point of care platform. Offer end to end solutions including compact systems, disposable kits, reagents, maintenance and training to streamline in clinic processing and improve outcomes.

Licensing Partnerships Past collaborations and asset transactions indicate openness to strategic deals; pursue licensing opportunities for regenerative therapy platforms or co development with pharma or device manufacturers to broaden market reach.

Training Services Provide clinical education, certification programs, and regulatory support to accelerate adoption; given the company size and revenue scale, services based offerings can drive recurring revenue and deepen clinician relationships.

Competitive Positioning Differentiate by speed to therapy and patient specific autologous approaches, targeting clinics currently using competing PRP or regenerative kits with integrated solutions that combine platforms, consumables, and support.